Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering. The company is based in Redwood City, California.
Market Cap | 74.147 Million | Shares Outstanding | 37.073 Million | Avg 30-day Volume | 1.373 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.32 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -26.759 Million |
Price to Book Value | 1.2866 | Operating Margin | 0.0 | Enterprise Value | 4.74 Million |
Current Ratio | 10.952 | EPS Growth | 0 | Quick Ratio | 10.561 |
1 Yr BETA | 0.1873 | 52-week High/Low | 4.62 / 0.39 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -84.3652 | Altman Z-Score | 1.2816 | Free Cash Flow to Firm | -21.728 Million |
Please sign in first
3.1 Million total shares from 1 transactions
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
MARTELL RON PRESIDENT, CEO AND DIRECTOR |
|
0 | 2023-03-17 | 2 |
MAHAL JEETINDER SINGH SEE REMARKS |
|
0 | 2023-03-17 | 2 |
|
0 | 2023-02-16 | 3 | |
CARLYLE HOLDINGS I GP SUB L.L.C. |
|
8,761,891 | 2023-01-27 | 2 |
|
4,549,606 | 2023-01-25 | 1 | |
VELAN CAPITAL INVESTMENT MANAGEMENT LP AVEGO HEALTHCARE CAPITAL, L.P. AVEGO HEALTHCARE CAPITAL HOLDINGS, LLC |
|
10,838,281 | 2023-01-25 | 1 |
CARLYLE HOLDINGS I GP SUB L.L.C. |
|
5,628,558 | 2022-08-01 | 2 |
|
78,045 | 2022-03-21 | 0 | |
|
5,628,558 | 2022-03-21 | 0 | |
LIS WILLIAM SEE REMARKS |
|
287,444 | 2022-03-21 | 0 |
|
78,045 | 2022-03-21 | 0 | |
HELLER KEVIN N. SEE REMARKS |
|
7,500 | 2022-03-21 | 0 |
|
78,045 | 2022-03-21 | 0 | |
|
78,045 | 2022-03-21 | 0 | |
|
78,045 | 2022-03-21 | 0 | |
|
2,300,000 | 2021-09-24 | 1 | |
|
2,300,000 | 2021-09-24 | 0 | |
QIMING U.S. HEALTHCARE FUND II, L.P. |
|
5,852,982 | 2021-09-24 | 0 |
|
2,300,000 | 2021-09-24 | 0 | |
|
No longer subject to file | 2021-04-21 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MARTELL RON - Director - Officer PRESIDENT, CEO AND DIRECTOR |
2023-03-20 17:59:47 -0400 | 2023-03-17 | A | 500,000 | a | 500,000 | direct | |||||||||
2023-03-20 18:00:57 -0400 | 2023-03-17 | A | 350,000 | a | 350,000 | direct | ||||||||||
2023-02-17 08:30:07 -0500 | 2023-02-16 | A | 109,383 | a | 109,383 | direct | ||||||||||
2023-02-03 16:13:55 -0500 | 2023-02-02 | A | 1,093,831 | a | 1,093,831 | direct | ||||||||||
CARLYLE GROUP INC. - > 10% Owner see footnotes ABINGWORTH LLP - > 10% Owner see footnotes CARLYLE HOLDINGS I GP INC. - > 10% Owner see footnotes CARLYLE HOLDINGS I GP SUB L.L.C. - > 10% Owner see footnotes CARLYLE HOLDINGS I L.P. - > 10% Owner see footnotes CG SUBSIDIARY HOLDINGS L.L.C. - > 10% Owner see footnotes TC GROUP, LLC - > 10% Owner see footnotes CARLYLE INVESTMENT MANAGEMENT LLC - > 10% Owner see footnotes CARLYLE GENESIS UK LLC - > 10% Owner see footnotes |
2023-01-31 17:24:21 -0500 | 2023-01-27 | P | 3,133,333 | $1.50 | a | 8,761,891 | indirect | 7.8788 | 12.1212 | 9.0909 | 26.0606 | 24 | 0.0 | 1 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
JASPER THERAPEUTICS INC JSPR | 2023-03-24 22:15:03 UTC | -59.6686 | 64.4886 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 21:45:03 UTC | -59.6686 | 64.4886 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 21:15:03 UTC | -59.6686 | 64.4886 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 20:45:03 UTC | -59.6686 | 64.4886 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 20:15:04 UTC | -59.6686 | 64.4886 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 19:45:03 UTC | -59.6686 | 64.4886 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 19:15:04 UTC | -59.6686 | 64.4886 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 18:45:04 UTC | -59.5171 | 64.3371 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 18:15:03 UTC | -59.5171 | 64.3371 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 17:45:03 UTC | -59.5171 | 64.3371 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 17:15:03 UTC | -59.5171 | 64.3371 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 16:45:03 UTC | -59.5171 | 64.3371 | 250000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 16:15:03 UTC | -59.5171 | 64.3371 | 200000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 15:45:03 UTC | -59.5171 | 64.3371 | 200000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 15:15:03 UTC | -59.5171 | 64.3371 | 200000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 14:45:03 UTC | -59.5171 | 64.3371 | 200000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 14:15:03 UTC | -59.5171 | 64.3371 | 150000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 13:45:03 UTC | -59.6749 | 64.2449 | 150000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 13:15:04 UTC | -59.6749 | 64.2449 | 150000 |
JASPER THERAPEUTICS INC JSPR | 2023-03-24 12:45:03 UTC | -59.6749 | 64.2449 | 150000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|